by Admin | Sep 8, 2022 | Delos News
We would like to congratulate Dr. Eric Huang, Operating Partner at Delos Capital for being presented with the prestigious 2022 Warren Alpert Foundation Prize! Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium...
by Admin | Feb 16, 2022 | Delos News
HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III....
by Admin | Sep 14, 2020 | Delos News, Portfolio News
BEDFORD, Mass., Sept. 14, 2020 /PRNewswire/ — Rejoni announced today that it has closed a $15 million Series A financing. The round was led by Ascension Ventures, with additional participation from Delos Capital and Sparta Group. Rejoni is using its...
by Admin | Dec 10, 2019 | Delos News
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in...
by Admin | Nov 27, 2019 | Delos News
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced the completion of a US$ 43 million (RMB 304 million) Series B...
by Admin | Sep 20, 2019 | Delos News
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing. Curamir...